Summary
TCMD Chart
New Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer Survivors
Abstract Presented at ASCO 2025 Annual Meeting Features Two-Month Data from the Largest Randomized Trial Ever Conducted Among Head and Neck Cancer Survivors Abstract Presented at ASCO 2025 Annual Meeting Features Two-Month Data from the Largest Randomized Trial Ever Conducted Among Head and Neck Cancer Survivors
Tactile Medical to Present at Upcoming Investor Conferences in June
MINNEAPOLIS, May 20, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will be participating in two upcoming investor conferences. Tactile Medical is scheduled to present at the William Blair 45th Annual Growth Stock Conference in Chicago on Tuesday, June 3, 2025, at 3:20 p.m. CST and at the Jefferies Global Healthcare Conference in New York on Wednesday, June 4, 2025, at 2:35 p.m. EST.
Tactile Systems Technology, Inc. (TCMD) Q1 2025 Earnings Call Transcript
Tactile Systems Technology, Inc. (NASDAQ:TCMD ) Q1 2025 Earnings Conference Call May 5, 2025 5:00 PM ET Company Participants Sam Bentzinger - Investor Relations, Gilmartin Group LLC Sheri Dodd - Chief Executive Officer Elaine Birkemeyer - Chief Financial Officer Conference Call Participants Margaret Kaczor Andrew - William Blair Ryan Zimmerman - BTIG Anderson Schock - B. Riley Securities Operator Welcome, ladies and gentlemen, to the First Quarter 2025 Earnings Conference Call for Tactile Medical.
Tactile Systems Technology Inc. Dividends
Tactile Systems Technology Inc. Earnings
| 4 Aug 2025 (60 Days) Date | | - Cons. EPS | - EPS |
| 5 May 2025 Date | | - Cons. EPS | - EPS |
| 18 Feb 2025 Date | | - Cons. EPS | 0.4 EPS |
| 4 Nov 2024 Date | | 0.18 Cons. EPS | 0.21 EPS |
| 5 Aug 2024 Date | | 0.12 Cons. EPS | 0.18 EPS |
| 4 Aug 2025 (60 Days) Date | | - Cons. EPS | - EPS |
| 5 May 2025 Date | | - Cons. EPS | - EPS |
| 18 Feb 2025 Date | | - Cons. EPS | 0.4 EPS |
| 4 Nov 2024 Date | | 0.18 Cons. EPS | 0.21 EPS |
| 5 Aug 2024 Date | | 0.12 Cons. EPS | 0.18 EPS |
Tactile Systems Technology Inc. (TCMD) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
What is the earnings per share?
When is the next earnings date?
Has Tactile Systems Technology Inc. ever had a stock split?
Tactile Systems Technology Inc. Profile
| Medical - Devices Industry | Healthcare Sector | Ms. Sheri Louise Dodd CEO | NASDAQ (NMS) Exchange | 87357P100 Cusip |
| US Country | 1,037 Employees | - Last Dividend | - Last Split | 28 Jul 2016 IPO Date |
Overview
Tactile Systems Technology, Inc. is a pioneering medical technology entity focused on designing, developing, and marketing innovative medical devices tailored to treat chronic diseases that are often neglected by the current healthcare model, predominantly in the United States. Founded in 1995 and strategically headquartered in Minneapolis, Minnesota, the company has carved a niche for itself by offering cutting-edge solutions that aim to improve the quality of life for patients suffering from conditions such as lymphedema, chronic venous insufficiency, and respiratory diseases. Through its commitment to advancing medical care at home, Tactile Systems Technology stands at the forefront of facilitating accessible and effective treatment options beyond the confines of traditional hospital settings.
Products and Services
- Flexitouch Plus system
A revolutionary pneumatic compression device, the Flexitouch Plus is designed to provide comprehensive treatment for lymphedema within the comfort of the patient's home. This system utilizes advanced technology to simulate manual lymphatic drainage therapy, which helps reduce swelling and manage symptoms effectively, providing relief to those suffering from this often debilitating condition.
- Entre Plus System
Understanding the challenges faced by individuals with venous disorders, Tactile Systems Technology introduced the Entre Plus System, a portable pneumatic compression device that caters to the at-home treatment of conditions such as lymphedema and chronic venous insufficiency, including the painful and hard-to-heal venous leg ulcers. This device offers a practical solution for patients to manage their conditions effectively from the comfort of their homes, enhancing their quality of life.
- Kylee mobile application
With the digital age revolutionizing healthcare management, Tactile Systems Technology developed Kylee, a user-friendly mobile application aimed at empowering patients to better understand lymphedema, monitor their symptoms and treatment progress, and seamlessly share this data with their healthcare providers. This innovative app fosters patient engagement and encourages active participation in their healthcare journey, promoting better outcomes.
- AffloVest
The AffloVest represents a significant advancement in respiratory care, offering a portable high frequency chest wall oscillation vest designed to aid patients struggling with retained pulmonary secretions due to conditions like bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Its portability ensures patients can receive consistent treatment, regardless of their location, making it a vital tool in managing respiratory conditions more effectively.
Contact Information
